An Open-label Study of Avastin in Combination With Chemotherapy Regimens as Second-line Treatment in Patients With Metastatic Colon or Rectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colon cancer; Rectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 May 2013 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 12 Aug 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01181609).
- 28 May 2010 Status changed from active, no longer recruiting to completed as reported by Roche website.